期刊文献+

心脏副神经节瘤1例并文献复习 被引量:2

Cardiac paraganglioma: report of one cases and review of literature
原文传递
导出
摘要 目的探讨心脏副神经节瘤的临床病理特征及鉴别诊断。方法对1例心脏副神经节瘤进行组织学观察、免疫组化染色和临床随访,并复习相关文献。结果肿瘤组织呈器官样结构,肿瘤细胞由主细胞及支持细胞构成。免疫组化:肿瘤细胞vimentin、S-100、CD56、CgA、Syn(+),而CK、CD68、GFAP(-),Ki-67阳性指数约5%。术后2年零3个月,无复发。结论心脏的副神经节瘤是罕见的副神经节肿瘤,组织病理学特点结合免疫组化标记有助于该肿瘤的诊断。 Objective To investigate the clinicopathologic features and differential diagnosis of cardiac paraganglioma.Methods One case of cardiac paraganglioma was observed histologically,with immunohistochemical staining and clinical follow-up,and the related literature was reviewed.Results Histologically,the tumor showed organ-like structure,and the tumor cells were composed of main cells and supporting cells.Immunohistochemical staining showed that the tumor cells were positive for Vim,S100,CD56,CGA and Syn,while CK,CD68 and GFAP were negative.The positive index of Ki-67 was about 5%.2 years and 3 months postoperatively,there was no recurrence.Conclusion Cardiac paraganglioma is a rare paraganglioma,and its histopathologic features combined with immunohistochemical markers are helpful in the diagnosis of this tumor.
作者 赵华 王凯 王鸿雁 郑建杰 ZHAO Hua;WANG Kai;WANG Hong-yan;ZHENG Jian-jie(Department of Pathology,the First Affiliated Hospital of Xi’an Jiaotong University,Xi'an 710061,China;Department of Cardiouascular Surgery,the First Affiliated Hospital of Xi’an Jiaotong University,Xi'an 710061,China)
出处 《诊断病理学杂志》 2020年第8期564-566,572,共4页 Chinese Journal of Diagnostic Pathology
关键词 心脏副神经节瘤 嗜铬细胞瘤 临床病理 免疫组化 Cardiac Paraganglioma Pheochromocytoma Clinical pathology Immunohistochemistry
  • 相关文献

参考文献3

二级参考文献26

  • 1Karasek D,Frysak Z,Pacak K. Genetic testing for pheochromocytoma[J].{H}Current Hypertension Reports,2010,(06):456-464.
  • 2Welander J,Stiderkvist P,Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas[J].{H}Endocrine Related Cancer,2011,(06):253-276.
  • 3Qi XP,Ma JM,Du ZF. RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family[J].PLoS One,2011,(05):e20353.
  • 4KloosRT,Eng C,Evans DB. Medullary thyroid cancer:management guidelines of the American Thyroid Association[J].{H}THYROID,2009,(06):565-612.
  • 5Qi XP,Ying RB,Ma JM. Case report:a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma[J].{H}FAMILIAL CANCER,2012,(01):131-136.
  • 6Qi XP,Chen XL,Ma JM. RET Proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China[J].{H}THYROID,2012,(01):1257-1265.
  • 7Eisenhofer G,Pacak K,Huynh TT. Catecholamine metabolomic and secretory phenotypes in phaeochwmocytoma[J].{H}Endocrine Related Cancer,2010,(01):97-111.
  • 8Woodward ER,Maher ER. Von Hippel-Lindau disease and endocrine tumour susce-ptibility[J].{H}Endocrine Related Cancer,2006,(02):415-425.
  • 9Srirangalingam U,Khoo B,Walker L. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours[J].{H}Endocrine Related Cancer,2009,(02):515-525.
  • 10Elder EE,Elder G,Larsson C. Pheochromocytoma and functional paraganglioma syndrome:no longer the 10% tumor[J].{H}Journal of Surgical Oncology,2005,(03):193-201.

共引文献32

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部